[Form 4] NEOGEN CORP Insider Trading Activity
Rhea-AI Filing Summary
Neogen Corp director Ronald D. Green had 2,071 restricted stock units (RSUs) vest on 10/07/2025 and those RSUs were settled into an equal number of shares of common stock at an effective price of $5.63 per share. After the settlement, Mr. Green directly owned 14,852 shares. The Form 4 was signed by an attorney-in-fact on 10/09/2025. The filing records a routine equity compensation settlement rather than an open-market purchase or sale.
Positive
- None.
Negative
- None.
Insights
Director RSU vesting shows alignment with shareholders through equity compensation.
The reported transaction documents the vesting and settlement of 2,071 RSUs into common shares on 10/07/2025, increasing the director's direct holdings to 14,852 shares. This is a standard compensation event where the RSUs convert to shares at the stated value.
Key dependencies include the company's equity award schedule and any trading-window or blackout restrictions that govern when shares can be sold. Near-term visibility: this is a settled award with no further conversion dates disclosed.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Restricted Stock Units | 2,071 | $5.63 | $12K |
| Exercise | Common Stock | 2,071 | $5.63 | $12K |
FAQ
What did Neogen (NEOG) report on Form 4 dated 10/07/2025?
At what price were the RSUs settled for Neogen (NEOG)?
Was the Form 4 filed jointly or by one reporting person?
Does the Form 4 indicate any derivative transactions or future exercisable awards?
AI-generated analysis. How Rhea-AI works. Not financial advice.